November 07, 2020
Video
Mark G. Kris, MD, discusses 1 of the major topics of discussion from the 15th Annual New York Lung Cancers Symposium, among other areas of focus at the meeting.
November 10, 2019
Video
Mark G. Kris, MD, discusses treatment options for MET-mutant non–small cell lung cancer.
July 12, 2019
Video
Mark G. Kris, MD, discusses the importance of delaying relapse in patients with EGFR-positive non–small cell lung cancer. He shares the significance of the findings from the phase III RELAY trial, where the goal was to delay the time to relapse by adding ramucirumab to erlotinib.
December 07, 2018
Video
Mark G. Kris, MD, discusses what is most important in treating patients with lung cancer today.
April 09, 2018
Video
Mark G. Kris, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the recent FDA approval of durvalumab (Imfinzi) for the treatment of patients with locally advanced, unresectable stage III non–small cell lung cancer.
November 15, 2013
Article
Mark G. Kris, MD, William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan-Kettering Cancer Center, gives an overview of current guidelines for molecular testing in lung cancer.